TCTR20140604001已完成1 期
Effectiveness of beta-glucan supplementation to interleukine-6, interleukine-10 and tumour necrosis factor alpha in overweight and obese subject
Core Chematis Co., Ltd0 个研究点目标入组 44 人开始时间: 2014年6月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21 Years 至 65 Years（—）
- 性别
- All
入选标准
- •BMI more than 23 kg m2
- •Agree to maintain current lifestyle e g diet and exercise during the trial
排除标准
- •-Major comorbidity e g CAD cancer
- •-Major psychiatric disorders
- •-Consumption of weigh loss products or actively attempting to loss weight
- •-Pregnant or lactating females
- •-Eating disorder or laxative abuse
- •-Received or stopped using drug treatment on non communicable chronic diseases than 3 months
- •-Lost body weight 5 kg during 6 months before starting experiment
- •-Current or recent participant in another clinical trial 90 days
研究者
相似试验
尚未招募
不适用
Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease PatientsChronic Obstructive Pulmonary Disease PatientsNCT05878834Chulalongkorn University72
已完成
2 期
Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.HyperlipidemiasNCT03857256Montreal Heart Institute263
已完成
3 期
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot UlcersChronic Diabetic Foot UlcersNCT00632008Biotec Pharmacon ASA122
进行中（未招募）
Unknown
Effectiveness of low doses of yeast beta-glucan 1,3/1,6 in adults with moderate stress in fighting respiratory infections, reducing fatigue, boosting the immune system and improving digestive healthRespiratory infections, fatigue, immune system, and digestive health of adults with moderate stressISRCTN48336189Mead Johnson Nutrition Malaysia200
已完成
1 期
Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT00533728Biotec Pharmacon ASA12